Oxycodone Lp Sandoz (Oxycodone Hydrochloride)

Oxycodone Hydrochloride, the active ingredient in Oxycodone Lp Sandoz, is an opioid analgesic presented as a prolonged‑release oral tablet for oral use. It is prescribed for managing moderate to severe pain in adult patients when other analgesics are insufficient. GNH USA supplies Oxycodone Lp Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oxycodone Lp Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxycodone Lp Sandoz is an opioid analgesic that acts on the central nervous system to relieve pain.

- Chronic cancer‑related pain: provides long‑lasting relief for patients with persistent tumor‑associated pain. - Post‑operative pain: manages moderate to severe pain after major surgical procedures. - Severe traumatic injury pain: controls intense pain following serious injuries such as fractures or burns. - Chronic non‑cancer pain: offers sustained analgesia for conditions like severe osteoarthritis when other treatments have failed.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Nausea: mild to moderate queasiness. - Drowsiness: increased sleepiness or sedation. - Dizziness: light‑headed feeling, especially when standing. - Dry mouth: decreased salivation. - Sweating: excess perspiration without exertion.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - Severe hypotension: marked drop in blood pressure. - Seizures: convulsive episodes, particularly with overdose. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Dependence and addiction: potential for physical and psychological dependence with prolonged use. - Adrenal insufficiency: rare hormonal imbalance affecting stress response.

When prescribing Oxycodone Lp Sandoz, clinicians should assess patient history and monitor for adverse reactions.

- Assess risk of respiratory depression: evaluate respiratory function before initiating therapy. - Evaluate for opioid tolerance: adjust dose only for patients with established opioid tolerance. - Monitor for signs of dependence: watch for cravings, withdrawal symptoms, or misuse behaviors. - Use caution in renal or hepatic impairment: dose adjustments may be required. - Avoid concurrent CNS depressants: limit use with alcohol, benzodiazepines, or other sedatives. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Oxycodone Lp Sandoz may interact with several medications, altering its efficacy or safety profile.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): increase oxycodone plasma levels and risk of respiratory depression. - CNS depressants (e.g., benzodiazepines, barbiturates, alcohol): additive sedative effects and heightened respiratory risk. - MAO inhibitors: may precipitate severe hypertension or serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may reduce conversion of oxycodone to its active metabolite, affecting analgesia. - Anticholinergic agents: may worsen constipation. - Diuretics: can increase risk of orthostatic hypotension. - Antihistamines: may intensify drowsiness. - Herbal supplements: St [       ]